— Know what they know.
Not Investment Advice
Also trades as: EYE.AX (ASX) · $vol 0M

ELXMF OTC

Nova Eye Medical Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +653.2% 1Y: -85.7% 3Y: -85.7% 5Y: -94.5%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 48 · $4.1M mcap · 233M float · 0.0004% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$4.1M
52W Range0.0019-0.1
Volume1,000
Avg Volume878
Beta0.93
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOThomas Spurling
Employees301
SectorHealthcare
IndustryMedical - Devices
IPO Date2010-01-20
107 Rundle Street
Kent Town, SA 5067
AU
61 8 8362 0193
About Nova Eye Medical Limited

Headquartered in Kent Town, Australia, and established in 1985, Nova Eye Medical Limited is dedicated to the development, manufacturing, and global commercialization of surgical solutions for eye conditions, with a primary focus on glaucoma. Their product lineup features the iTrack surgical system, engineered to reduce intraocular pressure in adult patients with open-angle glaucoma, alongside its evolution, iTrack Advance, which promotes natural ocular fluid drainage. For individuals with severe or intricate forms of glaucoma, they provide the Molteno3 drainage device. Additionally, the company offers 2RT, a unique laser technology aimed at treating early to intermediate age-related macular degeneration. Nova Eye Medical Limited maintains a significant international footprint, conducting operations across Australia, the United States, Europe, and the Asia Pacific region. The company officially adopted its current name in July 2020, having previously operated as Ellex Medical Lasers Limited.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms